Showing results (391-400 of 398) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 398 results.
The American Journal of Gastroenterology|November 30, 2000
Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic GroupT Andersson, E Hassall, P Lundborg, et al.
Lancet (London, England)|August 25, 2001
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trialL H Lindholm, H Anderson, T Ekbom, et al.
Blood Pressure|March 12, 1998
The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current statusL Hansson, T Hedner, L Lindholm, et al.
Lancet (London, England)|February 25, 1999
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialL Hansson, L H Lindholm, L Niskanen, et al.
Diabetes Care|February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, G R Dagenais, H C Gerstein, et al.
American Journal of Hypertension|July 1, 1997
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study GroupB Dahlöf, R Devereux, U de Faire, et al.
Hypertension (Dallas, Tex. : 1979)|December 18, 1998
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in HypertensionB Dahlöf, R B Devereux, S Julius, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|February 19, 2002
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combinationR G Asmar, G M London, M E O'Rourke, et al.
Pageof 40